USFDA grants fast track designation to Wockhardt novel antibiotic WCK 6777 Ruchika Sharma8 Oct 2024 10:30 AM ISTMumbai: Wockhardt has announced that its unique once-a-day, β-lactam enhancer based MDR-active antibiotic, WCK 6777 (Ertapenem/Zidebactam) has...
Wockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW summit in Dubai Ruchika Sharma27 Sept 2024 1:04 PM ISTMumbai: Founder Chairman of Wockhardt group, Dr Habil Khorakiwala was presented the Lifetime Achievement Award at the 10th Integrated Health...
Wockhardt Chairman Dr Habil Khorakiwala conferred with BIRAC Innovator Award 2024 Ruchika Sharma18 Sept 2024 1:07 PM ISTMumbai: Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise, conferred the "BIRAC Innovator Award 2024" to...
CDSCO issues Cancelled Lincence List of importers Susmita Roy9 Sept 2024 6:00 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has published a list of the details of importers whose permissions have been...
CDSCO Panel Approves Wockhardt's Protocol Amendment Proposal for antimicrobial drug Cefepime plus Zidebactam Dr. Divya Colin3 Sept 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Wockhardt's...
Wanbury ropes in Prakash Venkatraman as President of API business Ruchika Sharma16 Aug 2024 3:53 PM ISTMumbai: Wanbury Limited has announced the appointment of Prakash Venkatraman as President of the API business. With a stellar career...
Wockhardt plans to launch antibiotic Zaynich in early FY26 Ruchika Sharma30 Jun 2024 2:00 PM ISTMumbai: Wockhardt said that research and trials for the antibiotic Zaynich are advancing well, with plans for an early launch in FY26. Habil...
Wockhardt raises Rs 480 crores via QIP Ruchika Sharma30 March 2024 1:15 PM ISTWith the closure of its recent Qualified Institutional Placement (QIP), Wockhardt has now raised Rs 480 crores. The share allotment committee allotted...
Wockhardt gets CDSCO Panel nod to study Biphasic insulin aspart Dr. Divya Colin15 March 2024 5:30 PM ISTNew Delhi: Reviewing the protocol presented by the drug major Wockhardt, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Wockhardt loss narrows to Rs 86 crore in Q3 Ruchika Sharma17 Feb 2024 10:00 AM ISTNew Delhi: Pharmaceuticals firm Wockhardt Ltd has reported narrowing of consolidated net loss to Rs 86 crore for the third quarter ended December...
Wockhardt Gets CDSCO Panel Nod To study combination of cefepime and zidebactam. Dr. Divya Colin16 Jan 2024 5:00 PM ISTNew Delhi: The drug major Wockhardt has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Wockhardt gets CDSCO Panel Nod to study antimicrobial FDC Cefepime plus Tazobactum Dr. Divya Colin26 Nov 2023 3:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted permission to the...
